Blog - Health Technology Insights

December 22, 2025
HealthTech Staff Writer
HealthTech News, News, news

DESTINY-Endometrial02 Trial of ENHERTU Starts in HER2+ Cancer

The first patient has been treated in the DESTINY-Endometrial02 phase 3 trial, which is investigating ENHERTU (trastuzumab deruxtecan) as an adjuvant therapy for patients with HER2 expressing endometrial cancer....

December 22, 2025
HealthTech Staff Writer
HealthTech News, News, news

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study Merck KGaA, Darmstadt, Germany, a global leader in science and technology,...

December 22, 2025
Health Tech Staff Writer
HealthTech News, news, News

ACCO Brands to Acquire EPOS

Provides key third-party certifications across major unified communications platforms ACCO Brands Corporation, a global leader in branded office supplies, learning products, and technology accessories, has announced a definitive agreement...

December 22, 2025
HealthTech Staff Writer
HealthTech News, News, news

Connecticut HIE Adopts PIQXL Gateway to Boost Data Quality

Connie, Connecticut’s state-designated Health Information Exchange, is adopting Clinical Architecture’s PIQXL Gateway to improve the quality of patient data shared across healthcare organizations statewide. The platform allows Connie to...

December 22, 2025
HealthTech Staff Writer
HealthTech News, News, news

Adagio Medical Adds Executives to Boost ULTC Launch

Marie-Claude Jacques appointed Senior Vice President, Global Sales; Antwan Gipson joins as Senior Vice President, Manufacturing & Operations Adagio Medical Holdings, Inc., a and leader in catheter ablation technologies...

December 22, 2025
HealthTech Staff Writer
HealthTech News, News, news

Shionogi to Acquire Global Rights to RADICAVA ORS

Shionogi to purchase the rights and assets of the global RADICAVA business establishing a strong commercial platform in rare disease to support future launches Shionogi and Co., Ltd., headquartered...

December 22, 2025
HealthTech Staff Writer
HealthTech News, News, news

Shape Memory Medical Gains EU MDR for IMPEDE Plug

Shape Memory Medical Inc., a company focused on advancing shape memory polymer technology for endovascular treatments, has announced that its IMPEDE Embolization Plug product family has achieved certification as...

December 20, 2025
HealthTech Media Room
HealthTech News, News, news

Health Technology Insights: Latest News And Innovations – Roundup 19 December 2025

Welcome to your Weekly Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights, emerging trends, and must-know...

December 19, 2025
HealthTech Media Room
HealthTech News, news, News

Tryal Unveils AI-Powered Accelerator Platform for Clinical Trials

Tryal announced the launch of the new Tryal Accelerator, a next-generation AI-powered platform designed to dramatically improve the speed, quality, and consistency of clinical trial startup documentation. Built for...

December 19, 2025
HealthTech Media Room
HealthTech News, news, News

Health Universe and Kno2 Team Up for Instant Records and AI Insights

Health Universe announced a strategic partnership with Kno2, a federally designated QHIN, to eliminate manual chart chasing by turning nationwide patient records into structured, clinician-ready insights in minutes. Clinicians...

December 19, 2025
HealthTech Media Room
HealthTech News, News, news

INFINITT Expands Digital Pathology with Hamamatsu S360MD Scanner

NFINITT North America, a leader in advanced healthcare imaging solutions, is excited to announce the newest addition to its digital pathology platform: the FDA-cleared Hamamatsu NanoZoomer S360MD Slide Scanner,...

December 19, 2025
HealthTech Media Room
HealthTech News, News, news

Altimmune Reports Pemvidutide Hits 48-Week Goals in Phase 2b Trial

Improvements observed in key non-invasive markers of fibrosis across treatment arms versus placebo, with continued reductions from 24-week timepoint Altimmune, Inc., a late clinical-stage biopharmaceutical company developing therapies that address serious liver diseases,...

DESTINY-Endometrial02 Trial of ENHERTU Starts in HER2+ Cancer

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

ACCO Brands to Acquire EPOS

Connecticut HIE Adopts PIQXL Gateway to Boost Data Quality

Adagio Medical Adds Executives to Boost ULTC Launch

Shionogi to Acquire Global Rights to RADICAVA ORS

Shape Memory Medical Gains EU MDR for IMPEDE Plug

Health Technology Insights: Latest News And Innovations – Roundup 19 December 2025

Tryal Unveils AI-Powered Accelerator Platform for Clinical Trials

Health Universe and Kno2 Team Up for Instant Records and AI Insights

INFINITT Expands Digital Pathology with Hamamatsu S360MD Scanner

Altimmune Reports Pemvidutide Hits 48-Week Goals in Phase 2b Trial

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands

Download the Health Technology Insights Media Kit